In vivo confirmation of altered hepatic glucose metabolism in patients with liver fibrosis/cirrhosis by 18F-FDG PET/CT.
Niklas VerlohIngo EinspielerKirsten UtpatelKarin MenhartStefan BrunnerFrank HofheinzJörg van den HoffPhilipp WiggermannMatthias EvertChristian StroszczynskiDirk HellwigJirka GrossePublished in: EJNMMI research (2018)
Functional changes in liver parenchyma during liver fibrosis/cirrhosis affect hepatic glucose metabolism and significantly differ between stages of liver fibrosis/cirrhosis, classified according to the METAVIR scoring system, as demonstrated by LBR quantification by 18F-FDG PET/CT.
Keyphrases